AWM
MRNA icon

Activest Wealth Management’s Moderna MRNA Stock Holding History

Activest Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.45K Buy
135
+50
+59% +$2.59K ﹤0.01% 592
2026
Q1 		$4.32K Sell
85
-176
-67% -$8.21K ﹤0.01% 841
2025
Q4 		$7.7K Sell
261
-393
-60% -$10.7K ﹤0.01% 709
2025
Q3 		$16.9K Sell
654
-90
-12% -$2.51K ﹤0.01% 408
2025
Q2 		$20.5K Buy
744
+93
+14% +$2.45K ﹤0.01% 320
2025
Q1 		$18.5K Sell
651
-287
-31% -$10.2K 0.01% 302
2024
Q4 		$39K Sell
938
-386
-29% -$18.4K 0.01% 194
2024
Q3 		$88.5K Sell
1,324
-2,100
-61% -$193K 0.03% 132
2024
Q2 		$407K Buy
3,424
+3,213
+1,523% +$407K 0.13% 59
2024
Q1 		$22.5K Hold
211
– – 0.01% 167
2023
Q4 		$21K Sell
211
-20
-9% -$1.68K 0.01% 142
2023
Q3 		$23.9K Sell
231
-319
-58% -$35.6K 0.01% 129
2023
Q2 		$67K Buy
550
+312
+131% +$41.6K 0.05% 54
2023
Q1 		$35.1K Sell
238
-963
-80% -$159K 0.02% 99
2022
Q4 		$222K Sell
1,201
-63
-5% -$10.3K 0.07% 82
2022
Q3 		$159K Buy
1,264
+1,026
+431% +$156K 0.05% 97
2022
Q2 		$34K Hold
238
– – 0.02% 116
2022
Q1 		$41K Sell
238
-113
-32% -$19K 0.03% 114
2021
Q4 		$89K Buy
351
+69
+24% +$20.2K 0.06% 79
2021
Q3 		$109K Sell
282
-132
-32% -$48.7K 0.07% 75
2021
Q2 		$97K Sell
414
-219
-35% -$39.1K 0.07% 76
2021
Q1 		$83K Buy
+633
New +$91.7K 0.07% 76

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Activest Wealth Management's MRNA Position: Q2 2026 in Review

Activest Wealth Management increased its Moderna (MRNA) stake by 59% in Q2 2026, buying an estimated $2.59K and bringing the position to 135 shares worth $9.45K. The position accounts for ﹤0.01% of the portfolio, ranked #592.

Activest Wealth Management first reported a position in MRNA in Q1 2021 and has held it in 22 quarters since. The position peaked at $407K in Q2 2024. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Activest Wealth Management held 135 shares of Moderna worth $9.45K as of Q2 2026.
  • Activest Wealth Management bought 50 Moderna shares in Q2 2026, an estimated $2.59K.
  • Moderna made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #592 holding.
  • Activest Wealth Management first reported a position in Moderna in Q1 2021 and has held it in 22 quarters since.
  • Activest Wealth Management's Moderna position peaked at $407K in Q2 2024.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.